|
US2021069209A1
|
|
Novel pharmaceutical compositions and methods for menopause related anxiety and depression
|
|
US2020323873A1
|
|
Compositions and methods for treating alzheimer's disease and parkinson's disease
|
|
US2020323877A1
|
|
Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
|
|
US2020323876A1
|
|
Novel pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
|
|
US2020323871A1
|
|
Novel pharmaceutical compositions and methods for treating parkinson's and huntington's disease
|
|
US10639315B1
|
|
Pharmaceutical compositions and methods for treating Alzheimer's disease
|
|
US10639314B1
|
|
Method of treating Alzheimer's disease
|
|
US2020323867A1
|
|
Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
|
